Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Last Updated: March 30, 2023

Pai Holdings Pharm Company Profile

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $100
Remove trial restrictions

What is the competitive landscape for PAI HOLDINGS PHARM, and what generic and branded alternatives to PAI HOLDINGS PHARM drugs are available?

PAI HOLDINGS PHARM has fifty-one approved drugs.

Summary for Pai Holdings Pharm

US Patents:	0
Tradenames:	40
Ingredients:	35
NDAs:	51

Drugs and US Patents for Pai Holdings Pharm

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pai Holdings Pharm	CEFOTAN IN PLASTIC CONTAINER	cefotetan disodium	INJECTABLE;INJECTION	050694-002	Jul 30, 1993		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Pai Holdings Pharm	ZINACEF	cefuroxime sodium	INJECTABLE;INTRAMUSCULAR, INTRAVENOUS	050558-002	Oct 19, 1983	AB	RX	Yes	Yes		⤷ Sign Up				⤷ Sign Up
Pai Holdings Pharm	FORTAZ	ceftazidime	INJECTABLE;INJECTION	050578-001	Jul 19, 1985	AP	RX	Yes	Yes		⤷ Sign Up				⤷ Sign Up
Pai Holdings Pharm	ZANTAC IN PLASTIC CONTAINER	ranitidine hydrochloride	INJECTABLE;INJECTION	019593-002	Sep 27, 1991		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Pai Holdings Pharm	CEFOTAN	cefotetan disodium	INJECTABLE;INJECTION	050588-001	Dec 27, 1985	AP	RX	Yes	No		⤷ Sign Up				⤷ Sign Up
Pai Holdings Pharm	SODIUM POLYSTYRENE SULFONATE	sodium polystyrene sulfonate	POWDER;ORAL, RECTAL	088786-001	Sep 11, 1984		DISCN	Yes	No		⤷ Sign Up				⤷ Sign Up
Pai Holdings Pharm	BETAMETHASONE DIPROPIONATE	betamethasone dipropionate	OINTMENT, AUGMENTED;TOPICAL	206118-001	Nov 9, 2017	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Pai Holdings Pharm

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Pai Holdings Pharm	ZANTAC	ranitidine hydrochloride	INJECTABLE;INJECTION	019090-001	Oct 19, 1984	4,128,658	⤷ Sign Up
Pai Holdings Pharm	ZANTAC IN PLASTIC CONTAINER	ranitidine hydrochloride	INJECTABLE;INJECTION	019593-001	Dec 17, 1986	4,585,790*PED	⤷ Sign Up
Pai Holdings Pharm	ZANTAC IN PLASTIC CONTAINER	ranitidine hydrochloride	INJECTABLE;INJECTION	019593-002	Sep 27, 1991	4,521,431*PED	⤷ Sign Up
Pai Holdings Pharm	ZANTAC IN PLASTIC CONTAINER	ranitidine hydrochloride	INJECTABLE;INJECTION	019593-001	Dec 17, 1986	4,521,431*PED	⤷ Sign Up
Pai Holdings Pharm	ZANTAC IN PLASTIC CONTAINER	ranitidine hydrochloride	INJECTABLE;INJECTION	019593-001	Dec 17, 1986	4,128,658	⤷ Sign Up
Pai Holdings Pharm	ZANTAC	ranitidine hydrochloride	INJECTABLE;INJECTION	019090-001	Oct 19, 1984	4,521,431*PED	⤷ Sign Up
Pai Holdings Pharm	ZANTAC IN PLASTIC CONTAINER	ranitidine hydrochloride	INJECTABLE;INJECTION	019593-002	Sep 27, 1991	4,128,659	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Pai Holdings Pharm

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt

Merck

Boehringer Ingelheim

Dow

Johnson and Johnson

AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.